Hamilton, MT, United States of America

William M Whitmire

This inventor holds 2 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 2003.


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of William M. Whitmire

Introduction

William M. Whitmire is a notable inventor based in Hamilton, MT (US). He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid vaccines. With a total of 2 patents, his work focuses on innovative solutions to combat rickettsial diseases.

Latest Patents

William's latest patents include groundbreaking research on nucleic acid vaccines against rickettsial diseases. These vaccines contain genes designed to protect both animals and humans from these diseases. Additionally, his patents describe polypeptides and methods for using these polypeptides to detect antibodies to pathogens, showcasing his commitment to advancing medical science.

Career Highlights

William M. Whitmire is affiliated with the University of Florida Research Foundation Inc., where he continues to push the boundaries of research and innovation. His work has the potential to impact public health significantly, particularly in the prevention and detection of infectious diseases.

Collaborations

Some of his notable coworkers include Anthony F. Barbet and Michael V. Bowie. Their collaborative efforts contribute to the advancement of research in the field of vaccines and disease prevention.

Conclusion

William M. Whitmire's contributions to the field of biotechnology through his patents and research are invaluable. His work in developing nucleic acid vaccines represents a significant step forward in combating rickettsial diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…